Oxygen-ozone immunoceutical therapy in COVID-19 outbreak:
facts and figures.
Giovanni Ricevuti (1), Marianno Franzini (2), Luigi Valdenassi (3)
(1) Department of Drug Science, University of Pavia, Italy, High School in Oxygen Ozone Therapy,University of Pavia
(2) SIOOT International, Comunian Clinic, Gorle (BG), High School in Oxygen Ozone Therapy,University of Pavia
(3) SIOOT, Italian Society of Oxygen Ozone Therapy, High School in Oxygen Ozone Therapy,University of Pavia, Italy
The problems related to the approach to the outbreak of COVID-19 in the world require that all possible effective treatment options be explored. The clinical criterion of the researcher is not to refuse a priori, but to verify and evaluate the proposals that are made. Italian Society of Oxygen Ozone Therapy (SIOOT)
proposed to the Italian ISS (Italian Institute of Health) to use oxygen ozone therapy (O2O3) in patients with COVID-19. The ISS has said on 24 March 2020 that it is possible to use it in the light of scientific considerations:
Although the proposal is supported by a certain rational basis, the data actually available in relation to the proposed indication consist essentially in demonstrating the effectiveness of ozone in killing SARS virus in monkey cells, and clinical experience of the benefit in patients with bronchopulmonia. However, as the proposal appears to be shared and supported by clinical centers experienced in the treatment of viral pneumonia, treatment could, if
deemed appropriate, be carried out under the responsibility of the physician, after obtaining the informed consent of the patient.
Considering the “experimental” character of the use this indication, which also requires specific medical experience and the availability of appropriate instruments, it is considered appropriate to acquire also the opinion of the Ethics Committee.
Read the whole report in attached PDF: